Trent Evans

Trent Evans is a Senior Scientist at Vesalius Therapeutics, with previous experience as a Scientist II at the same company. Prior to that, Trent worked as a Postdoctoral Research Associate at Washington University in St. Louis. Trent's research focuses on metabolic engineering, synthetic biology, and infectious disease. Trent completed a PhD in Molecular Cell Biology at Washington University School of Medicine in St. Louis, and holds a Master's degree in Physiology from the University of Colorado Boulder, as well as a Bachelor's degree in Kinesiology and Exercise Science from the University of Wisconsin-Madison.